Smoking and Chronic Obstructive Pulmonary Disease (COPD). Parallel Epidemics of the 21st Century

  title={Smoking and Chronic Obstructive Pulmonary Disease (COPD). Parallel Epidemics of the 21st Century},
  author={Rafael Laniado-Labor{\'i}n},
  journal={International Journal of Environmental Research and Public Health},
  pages={209 - 224}
  • R. Laniado-Laborín
  • Published 1 January 2009
  • Medicine
  • International Journal of Environmental Research and Public Health
One hundred million deaths were caused by tobacco in the 20th century, and it is estimated that there will be up to one billion deaths attributed to tobacco use in the 21st century. Chronic obstructive pulmonary disease (COPD) is rapidly becoming a global public health crisis with smoking being recognized as its most important causative factor. The most effective available treatment for COPD is smoking cessation. There is mounting evidence that the rate of progression of COPD can be reduced… 

Figures and Tables from this paper

How to Detect Tobacco-related Vasculopathy: Are We There Yet?
Although there is evidence of a histologically defined tobacco-related vasculopathy, radiographically detected vascular pruning may not be a surrogate, at least when characterizing a “healthy” population of smokers.
Smoking Cessation Intervention: An Evidence-Based Approach
Evidence-based guidelines recommend nicotine replacement therapy, bupropion SR, and varenicline as effective alternatives for smoking cessation therapy, especially when combined with behavioral interventions.
Smoking cessation effectiveness in smokers with COPD and asthma under real life conditions.
Association of COPD and Lung Cancer: How Does COPD Management Change the Outcome of Treatment of Lung Cancer?
Improved understanding of the links between COPD and lung cancer and biomarkers that are more reliable may make this approach viable and it may be possible to treat COPD patients with targeted therapies to reduce the risk of development of lung cancer.
Evaluation of Individuals at Risk for COPD: Beyond the Scope of the Global Initiative for Chronic Obstructive Lung Disease.
The Global initiative for chronic Obstructive Lung Disease (GOLD) Strategy is a valuable tool for clinicians in the diagnosis and management of patients with established chronic obstructive pulmonary
Frequency of COPD in health care workers who smoke
The presence of COPD in health care workers who smoke was associated with higher nicotine dependence and was comparable with that in the general population.
Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer
It is highlighted that the major health problem of COPD can be alleviated via smoking cessation, early diagnosis, and abandonment of the usage of biomass fuels on a global basis.
The Degree of Smoking for Out Patient with COPD in Padang
  • D. Hasni, Nilas Warlem
  • Medicine
    Proceedings of the Proceedings of the 1st EAI International Conference on Medical And Health Research, ICoMHER November 13-14th 2018, Padang, West Sumatera, Indonesia
  • 2019
It can be concluded that the highest percentage of COPD patients is heavy smokers in the city of Padang and the Brinkman index value was heavy at 47.2%.
Correlation of haematocrit and smoking score with s everity of Chronic obstructive pulmonary disease
The correlation of haematocrit and smoking score in pack years with severity of COPD and the risk for polycythemia was identified and was very high in heavy smokers.


Smoking cessation in chronic obstructive pulmonary disease.
Smoking and COPD: what really are the risks?
There is now evidence that most smokers develop some respiratory impairment due to COPD, and one of the most informative recent studies addressing this issue is described.
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
It is suggested that the observed persistent airway inflammation in patients with chronic obstructive pulmonary disease is related to repair of tissue damage in the airways.
Smoking cessation: effects on symptoms, spirometry and future trends in COPD.
The expected results of sustained quitting smoking on subsequent lung disease, particularly chronic obstructive pulmonary disease (COPD), rather than the approaches which health professionals can use to aid an individual to become an ex-smoker are discussed.
Global burden of COPD: risk factors, prevalence, and future trends
The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD
Smokers diagnosed with COPD stopped smoking significantly more often than those with normal lung function and the point-prevalence abstinence rate and prolonged abstinence rate at 6 and 12 months increased yearly and in smokers with COPd at year 3 was 29%, 28%, and 25%, respectively.
Helping people to stop smoking: the new smoking cessation guidelines
The total social, economic, and health related cost to society of smoking is enormous, and prevention of smoking therefore deserves to be prioritised.
Chronic obstructive pulmonary disease: the disease and its burden to society.
As exacerbations and hospitalizations represent an important driver of the cost and morbidity of COPD, high priority should be given to interventions aimed at delaying the progression of disease, preventing exacerbations, and reducing the risk of comorbidities to alleviate the clinical and economic burden of disease.
The natural history of chronic airflow obstruction.
Severe or fatal obstructive lung disease could be prevented by screening smokers' lung function in early middle age if those with reduced function could be induced to stop smoking.
Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease
Public policies aimed at preventing public smoking may reduce the burden of COPD-related death and disability, both by reducing direct smoking and ETS exposure.